benzoxazoles has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, E; Liu, P; Liu, Y; Lv, H; Tang, X; Wang, M; Zhong, P; Zhong, W; Zhou, C; Zou, Q | 1 |
| Fitch, BA; Fruman, DA; Janes, MR; Lee, JS; Mallya, S; So, L | 1 |
2 other study(ies) available for benzoxazoles and Lymphoma
| Article | Year |
|---|---|
Benzoxazole Derivative K313 Induces Cell Cycle Arrest, Apoptosis and Autophagy Blockage and Suppresses mTOR/p70S6K Pathway in Nalm-6 and Daudi Cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzoxazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leukocytes, Mononuclear; Lymphoma; Mice; RAW 264.7 Cells; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Benzoxazoles; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance; Gene Knockdown Techniques; Humans; Lymphoma; Phosphoproteins; Pyrimidines; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases | 2014 |